Prospective Derivation of a Living Organoid Biobank of Colorectal Cancer Patients

Cited by (1,001)

Items 701–800 of 1,001

1. Molecular characterization of organoids derived from pancreatic intraductal papillary mucinous neoplasms
   Bo Huang, María Aurora Martínez Trujillo, Kohei Fujikura, Miao‐Zhen Qiu, Fei Chen, Matthäus Felsenstein, Cancan Zhou, Michael Francis Skaro, Christian D. Gauthier, Anne M. Macgregor‐Das et al. · 2020 · The Journal of Pathology
2. Organoid culture system for patient-derived lung metastatic osteosarcoma
   Aina He, Yujing Huang, Wanying Cheng, Deng Zhang, Weiwei He, Yueqing Bai, Chao Gu, Zhongping Ma, Zhenfang He, Guifan Si et al. · 2020 · Medical Oncology
3. Differential reprogramming of breast cancer subtypes in 3D cultures and implications for sensitivity to targeted therapy
   Esmee Koedoot, Liesanne Wolters, Marcel Smid, Peter Stoilov, Gerhard A. Burger, Bram Herpers, Kuan Yan, Leo Price, John W.M. Martens, Sylvia E. Le Dévédec et al. · 2021 · Scientific Reports
4. Biobanking of human gut organoids for translational research
   Francesca Marta Perrone, Matthias Zilbauer · 2021 · Experimental & Molecular Medicine
5. Endometrial Organoids: A New Model for the Research of Endometrial-Related Diseases†
   Zhiyue Gu, Shuangzheng Jia, Song Liu, Jinhua Leng · 2020 · Biology of Reproduction
6. Organoids: A new approach in toxicity testing of nanotherapeutics
   Showkat Ul Nabi, Sofi Imtiyaz Ali, Muzafar Ahmad Rather, Wajid Mohammad Sheikh, Mehvish Altaf, Hemant Singh, Peerzada Tajamul Mumtaz, Narayan Chandra Mishra, Sheikh Uzma Nazir, Showkeen Muzamil Bashir · 2021 · Journal of Applied Toxicology
7. Multifocal Organoid Capturing of Colon Cancer Reveals Pervasive Intratumoral Heterogenous Drug Responses
   Soon‐Chan Kim, Ji Won Park, Ha‐Young Seo, Min Jung Kim, Jae‐Hyeon Park, Ga‐Hye Kim, Ja Oh Lee, Young‐Kyoung Shin, Jeong Mo Bae, Bon‐Kyoung Koo et al. · 2021 · Advanced Science
8. Establishment of a large-scale patient-derived high-risk colorectal adenoma organoid biobank for high-throughput and high-content drug screening
   Zhongguang Luo, Bangting Wang, Feifei Luo, Yumeng Guo, Ning Jiang, Jinsong Wei, Xin Wang, Yujen Tseng, Jian Chen, Bing Tian Zhao et al. · 2023 · BMC Medicine
9. Integration of pan-omics technologies and three-dimensional in vitro tumor models: an approach toward drug discovery and precision medicine
   Anmi Jose, Pallavi Kulkarni, Jaya Thilakan, Murali Munisamy, Anvita Gupta Malhotra, Jitendra Singh, Ashok Kumar, Vivek M. Rangnekar, Neha Arya, Mahadev Rao · 2024 · Molecular Cancer
10. Stem cell therapy: a revolutionary cure or a pandora's box
    Hany E. S. Marei · 2025 · Stem Cell Research & Therapy
11. Blocking Wnt Secretion Reduces Growth of Hepatocellular Carcinoma Cell Lines Mostly Independent of β-Catenin Signaling
    Wenhui Wang, Lei Xu, Pengyu Liu, Kiran Jairam, Yuebang Yin, Kan Chen, Dave Sprengers, Maikel Petrus Peppelenbosch, Qiuwei Pan, Ron Smits · 2016 · Neoplasia
12. Comparative Study of Organoids from Patient-Derived Normal and Tumor Colon and Rectal Tissue
    Alba Costales‐Carrera, Asunción Fernández‐Barral, Pilar Bustamante‐Madrid, Orlando Domı́nguez, Laura Guerra, Ramón Cantero, Luis del Peso, Aurora Burgos, Antonio Barbáchano, Alberto Múñoz · 2020 · Cancers
13. Reconstructing the tumor architecture into organoids
    Zhimin Luo, Xingwu Zhou, Kalpana Mandal, Na He, Wally Wennerberg, Moyuan Qu, Xing Jiang, Wujin Sun, Ali Khademhosseini · 2021 · Advanced Drug Delivery Reviews
14. Generation and initial characterization of novel tumour organoid models to study human pancreatic cancer‐induced cachexia
    Rianne D.W. Vaes, David P.J. van Dijk, Tessa T.J. Welbers, Marinus J. Blok, Merel R. Aberle, Lara Rosaline Heij, Sylvia F. Boj, Steven W.M. Olde Damink, Sander S. Rensen · 2020 · Journal of Cachexia Sarcopenia and Muscle
15. Subversion of Niche-Signalling Pathways in Colorectal Cancer: What Makes and Breaks the Intestinal Stem Cell
    Nathalie Sphyris, Michael C. Hodder, Owen James Sansom · 2021 · Cancers
16. Living biobank-based cancer organoids: prospects and challenges in cancer research
    Haixin Li, Hongkun Liu, Kexin Chen · 2022 · Cancer Biology and Medicine
17. Patient-derived tumor-like cell clusters for personalized chemo- and immunotherapies in non-small cell lung cancer
    Shenyi Yin, Ying Yu, Nan Wu, Minglei Zhuo, Yanmin Wang, Yanjie Niu, Yiqian Ni, Fang Hu, Cuiming Ding, Hongsheng Liu et al. · 2024 · Cell stem cell
18. Crosstalk between microbiota, pathogens and the innate immune responses
    Claudia Günther, Christine Josenhans, Jan Wehkamp · 2016 · International Journal of Medical Microbiology
19. Human intestinal epithelium in a dish: Current models for research into gastrointestinal pathophysiology
    Manuel Noben, Wiebe Vanhove, Kaline Arnauts, Anabela Santo Ramalho, Gert Van Assche, Séverine Vermeire, Catherine M. Verfaillie, Marc Ferrante · 2017 · United European Gastroenterology Journal
20. Characterization of genetic intratumor heterogeneity in colorectal cancer and matching patient‐derived spheroid cultures
    Sigrid S. Árnadóttir, Maria Jeppesen, Philippe Lamy, Jesper B. Bramsen, Iver Nordentoft, Michael Knudsen, Søren Vang, Mogens Rørbæk Madsen, Maria Thastrup, Jacob Thastrup et al. · 2017 · Molecular Oncology
21. Establishing Pure Cancer Organoid Cultures: Identification, Selection and Verification of Cancer Phenotypes and Genotypes
    Nina Wallaschek, Carolin Niklas, Malvika Pompaiah, Armin Wiegering, Christoph‐Thomas Germer, Stefan Kircher, Stephanie Brändlein, Katja Maurus, Andreas Rosenwald, Helen H.N. Yan et al. · 2019 · Journal of Molecular Biology
22. Aberrant KIF23 expression is associated with adverse clinical outcome and promotes cellular malignant behavior through the Wnt/β-catenin signaling pathway in Colorectal Cancer
    Zhiyu Ji, Aoning Mi, Mengmeng Li, Quanying Li, Changjiang Qin · 2021 · Journal of Cancer
23. Establishment of oxaliplatin-resistant gastric cancer organoids: importance of myoferlin in the acquisition of oxaliplatin resistance
    Kenji Harada, Naoya Sakamoto, Shoichi Ukai, Yusuke Yamamoto, Quốc Thắng Phạm, Daiki Taniyama, Ririno Honma, Ryota Maruyama, Tsuyoshi Takashima, Hiroshi Ota et al. · 2021 · Gastric Cancer
24. Organoids for toxicology and genetic toxicology: applications with drugs and prospects for environmental carcinogenesis
    Angela L. Caipa Garcia, Volker Manfred Arlt, David H. Phillips · 2021 · Mutagenesis
25. An update of label-free protein target identification methods for natural active products
    Zhao Cui, Caifeng Li, Peng Chen, Hongjun Yang · 2022 · Theranostics
26. Colorectal Cancer Develops Inherent Radiosensitivity That Can Be Predicted Using Patient-Derived Organoids
    Kuo-Shun Hsu, Mohammad Adileh, Maria Laura Martin, Vladimir Makarov, Jiapeng Chen, Chao Wu, Sahra Bodo, Stefan Klingler, Charles-Etienne Gabriel Sauvé, Bryan C. Szeglin et al. · 2022 · Cancer Research
27. A suspension technique for efficient large-scale cancer organoid culturing and perturbation screens
    Stacey Price, Shriram G. Bhosle, Emanuel Gonçalves, Xiaodun Li, Dylan Peter McClurg, Syd Barthorpe, Alexandra Beck, Caitlin Hall, Howard W. Lightfoot, Luke Farrow et al. · 2022 · Scientific Reports
28. Flourishing tumor organoids: History, emerging technology, and application
    Qian Yang, Mengmeng Li, Xinming Yang, Zian Xiao, Xinying Tong, Ayinuer Tuerdi, Shisheng Li, Lanjie Lei · 2023 · Bioengineering & Translational Medicine
29. Engineered biomimetic hydrogels for organoids
    Yihan Li, Qimanguli Saiding, Zhen Wang, Wenguo Cui · 2023 · Progress in Materials Science
30. Organoids in the oral and maxillofacial region: present and future
    Yufei Wu, Xiang Li, Hanzhe Liu, Xiao Yi Yang, Rui Li, Hui Zhao, Zhengjun Shang · 2024 · International Journal of Oral Science
31. PharmaFormer predicts clinical drug responses through transfer learning guided by patient derived organoid
    Yuru Zhou, Quanhui Dai, Yanming Xu, Shuang Wu, Minzhang Cheng, Bing Tian Zhao · 2025 · npj Precision Oncology
32. Gastroenteropancreatic neuroendocrine neoplasms: genes, therapies and models
    Kenta Kawasaki, Masayuki Fujii, Toshiro Sato · 2018 · Disease Models & Mechanisms
33. Development of Patient-Derived Preclinical Platform for Metastatic Pancreatic Cancer: PDOX and a Subsequent Organoid Model System Using Percutaneous Biopsy Samples
    Sung Yong Choi, A-Ra Jeon, Min Kyeong Kim, Yu‐Sun Lee, Ji-Eun Im, Jung-Wook Koh, Sung‐Sik Han, Sun‐Young Kong, Kyong‐Ah Yoon, Young Hwan Koh et al. · 2019 · Frontiers in Oncology
34. Current and Future Horizons of Patient-Derived Xenograft Models in Colorectal Cancer Translational Research
    Akira Inoue, Angela K. Deem, Scott Kopetz, Timothy Paul Heffernan, Giulio Francesco Draetta, Alessandro Carugo · 2019 · Cancers
35. Increased proton-sensing receptor GPR4 signalling promotes colorectal cancer progression by activating the hippo pathway
    Minhao Yu, Ran Cui, Yizhou Huang, Yang Luo, Shao‐Lan Qin, Ming Zhong · 2019 · EBioMedicine
36. Integrated Biobanking and Tumor Model Establishment of Human Colorectal Carcinoma Provides Excellent Tools for Preclinical Research
    Christina Susanne Mullins, Bianca Micheel, Stephanie Matschos, Matthias Leuchter, Florian Bürtin, Mathias Krohn, Maja Hühns, Ernst Klar, Friedrich Prall, Michael Linnebacher · 2019 · Cancers
37. Plocabulin Displays Strong Cytotoxic Activity in a Personalized Colon Cancer Patient-Derived 3D Organoid Assay
    Alba Costales‐Carrera, Asunción Fernández‐Barral, Pilar Bustamante‐Madrid, Laura Guerra, Ramón Cantero, Antonio Barbáchano, Alberto Múñoz · 2019 · Marine Drugs
38. Adenylosuccinate lyase is oncogenic in colorectal cancer by causing mitochondrial dysfunction and independent activation of NRF2 and mTOR-MYC-axis
    Stephanie Taha‐Mehlitz, Gaia Bianco, Mairene Coto‐Llerena, Venkatesh Kancherla, Glenn R. Bantug, John Gallon, Caner Ercan, Federica Panebianco, Serenella Eppenberger‐Castori, Marco von Strauss et al. · 2021 · Theranostics
39. Technologies to Assess Drug Response and Heterogeneity in Patient-Derived Cancer Organoids
    Melissa C. Skala, Dustin A. Deming, Jeremy D. Kratz · 2022 · Annual Review of Biomedical Engineering
40. Advances in the application of 3D tumor models in precision oncology and drug screening
    Xiaoyong Guan, Shigao Huang · 2022 · Frontiers in Bioengineering and Biotechnology
41. Prediction of Clinical Precision Chemotherapy by Patient‐Derived 3D Bioprinting Models of Colorectal Cancer and Its Liver Metastases
    Hang Sun, Lejia Sun, Xindi Ke, Lijuan Liu, Changcan Li, Bao Jin, Peipei Wang, Zhuoran Jiang, Hong Zhao, Zhiying Yang et al. · 2023 · Advanced Science
42. Exploring Experimental Models of Colorectal Cancer: A Critical Appraisal from 2D Cell Systems to Organoids, Humanized Mouse Avatars, Organ-on-Chip, CRISPR Engineering, and AI-Driven Platforms—Challenges and Opportunities for Translational Precision Oncology
    Ahad Al-Kabani, Bintul Huda, Jewel Haddad, Maryam Yousuf, Farida Bhurka, Faika Ajaz, Rajashree Patnaik, Shirin Jannati, Yajnavalka Banerjee · 2025 · Cancers
43. Pluripotent stem cell-derived kidney organoids: An in vivo-like in vitro technology
    Frans Schutgens, Marianne Christina Verhaar, Maarten B. Rookmaaker · 2016 · European Journal of Pharmacology
44. Wnt Drug Discovery: Weaving Through the Screens, Patents and Clinical Trials
    Benjamin C. Lu, Brooke Green, Jacqueline Farr, Flávia Lopes, Terence J. Van Raay · 2016 · Cancers
45. Winding back Wnt signalling: potential therapeutic targets for treating gastric cancers
    Dustin James Flanagan, Elizabeth Vincan, Toby James Phesse · 2017 · British Journal of Pharmacology
46. Specific Labeling of Stem Cell Activity in Human Colorectal Organoids Using an ASCL2-Responsive Minigene
    Koen C. Oost, Lisa van Voorthuijsen, Arianna Fumagalli, Rik G.H. Lindeboom, Joep Sprangers, Manja Omerzu, Maria J. Rodríguez Colman, Maria C. Heinz, Ingrid Verlaan-Klink, Madelon M. Maurice et al. · 2018 · Cell Reports
47. Generation of 3D human gastrointestinal organoids: principle and applications
    Mengxian Zhang, Yuan Liu, Ye‐Guang Chen · 2020 · Cell Regeneration
48. Patient-Derived Tumor Organoids: New Progress and Opportunities to Facilitate Precision Cancer Immunotherapy
    Ji Wang, Chao Chen, Lu Wang, Mingjun Xie, Xinyang Ge, Sufan Wu, Yong He, Xiaozhou Mou, Chenyang Ye, Yi Sun · 2022 · Frontiers in Oncology
49. Gastric Organoids: Progress and Remaining Challenges
    Min-Jiao Pang, Joseph Burclaff, Ramon U. Jin, Mahliyah Adkins-Threats, Luciana H. Osaki, Yunan Han, Jason C. Mills, Zhi‐Feng Miao, Zhen-Ning Wang · 2021 · Cellular and Molecular Gastroenterology and Hepatology
50. CRISPR screens reveal convergent targeting strategies against evolutionarily distinct chemoresistance in cancer
    Chunge Zhong, Wenjie Jiang, Yingjia Yao, Zexu Li, You Li, Shengnan Wang, Xiaofeng Wang, Wenjuan Zhu, Siqi Wu, Jing Wang et al. · 2024 · Nature Communications
51. Adult gastric stem cells and their niches
    Sina Bartfeld, Bon‐Kyoung Koo · 2017 · Wiley Interdisciplinary Reviews Developmental Biology
52. From organoids to organs: Bioengineering liver grafts from hepatic stem cells and matrix
    Jorke Willemse, Ruby Lieshout, Luc J. W. van der Laan, Monique M. A. Verstegen · 2017 · Best Practice & Research Clinical Gastroenterology
53. Models for Understanding Resistance to Chemotherapy in Liver Cancer
    José J.G. Marı́n, Elisa Herráez, Elisa Lozano, Rocı́o I.R. Macı́as, Óscar Briz · 2019 · Cancers
54. Patient-derived organoids (PDOs) as a novel in vitro model for neuroblastoma tumours
    Pina Fusco, B. Parisatto, Elena Rampazzo, Luca Persano, Chiara Frasson, Annamaria Di Meglio, A Leslz, L. Santoro, Barbara Cafferata, Angelica Zin et al. · 2019 · BMC Cancer
55. Recreating Tumour Complexity in a Dish: Organoid Models to Study Liver Cancer Cells and their Extracellular Environment
    Gilles S. van Tienderen, Bas Groot Koerkamp, Jan N.M. IJzermans, Luc J. W. van der Laan, Monique M. A. Verstegen · 2019 · Cancers
56. Extracellular Matrix-Based Hydrogels to Tailoring Tumor Organoids
    Hyun Jin Lee, Siwon Mun, Duc Minh Pham, Pilnam Kim · 2021 · ACS Biomaterials Science & Engineering
57. Emerging role of G9a in cancer stemness and promises as a therapeutic target
    Joshua R. Haebe, Christopher J. Bergin, Tamara Sandouka, Yannick D. Benoit · 2021 · Oncogenesis
58. Dual targeting of MAPK and PI3K pathways unlocks redifferentiation of Braf-mutated thyroid cancer organoids
    Hélène Lasolle, Andréa Alex Schiavo, Adrien Tourneur, Pierre Gillotay, Bárbara F. Fonseca, Lucieli Ceolin, Olivier Monestier, Benilda Aganahi, Laura Chomette, Marina M. L. Kizys et al. · 2023 · Oncogene
59. New tools for old drugs: Functional genetic screens to optimize current chemotherapy
    Nora M. Gerhards, Sven Rottenberg · 2018 · Drug Resistance Updates
60. Mammary fibroblasts reduce apoptosis and speed estrogen-induced hyperplasia in an organotypic MCF7-derived duct model
    Molly M. Morgan, Megan K. Livingston, Jay W. Warrick, Eli M. Stanek, Elaine T. Alarid, David J. Beebe, Brian P. Johnson · 2018 · Scientific Reports
61. Malignant ascites-derived organoid (MADO) cultures for gastric cancer in vitro modelling and drug screening
    Jie Li, Huawei Xu, Lixing Zhang, Lele Song, Dan Feng, Xiaobo Peng, Meihong Wu, Yang Zou, Bin Wang, Lixing Zhan et al. · 2019 · Journal of Cancer Research and Clinical Oncology
62. Patient-Derived In Vitro Models for Drug Discovery in Colorectal Carcinoma
    George M. Ramzy, Thibaud Koessler, Eloise Ducrey, Thomas McKee, Frédéric Ris, Nicolas Christian Buchs, Laura Rubbia‐Brandt, Pierre‐Yves Dietrich, Patrycja M. Nowak-Sliwinska · 2020 · Cancers
63. Microfluidics for interrogating live intact tissues
    Lisa F. Horowitz, A. D. Rodriguez, Tyler R. Ray, Albert Folch · 2020 · Microsystems & Nanoengineering
64. Farewell to Animal Testing: Innovations on Human Intestinal Microphysiological Systems
    Kang, Tae, Kim, Hyun · 2016 · Micromachines
65. Biomaterials for intestinal organoid technology and personalized disease modeling
    Akira Hirota, Shaikha AlMusawi, Abdolrahman Shams Nateri, Paloma Ordóñez‐Morán, Masamichi Imajo · 2021 · Acta Biomaterialia
66. Accelerating precision anti-cancer therapy by time-lapse and label-free 3D tumor slice culture platform
    Fuqiang Xing, Yucheng Liu, Shigao Huang, Xueying Lyu, Sek Man Su, Un In Chan, Pei‐Chun Wu, Yinghan Yan, Nana Ai, Jianjie Li et al. · 2021 · Theranostics
67. Using patient-derived tumor organoids from common epithelial cancers to analyze personalized T-cell responses to neoantigens
    Anup Y. Parikh, Robert Masi, Billel Gasmi, Ken‐ichi Hanada, Maria R. Parkhurst, Jared J. Gartner, Sivasish Sindiri, Todd D. Prickett, Paul F. Robbins, Nikolaos Zacharakis et al. · 2023 · Cancer Immunology Immunotherapy
68. Mass production of lumenogenic human embryoid bodies and functional cardiospheres using in-air-generated microcapsules
    Bas van Loo, Simone A. ten Den, Nuno Araújo‐Gomes, Vincent de Jong, Rebecca R. Snabel, Maik Schot, José M. Rivera‐Arbeláez, Gert Jan C. Veenstra, R. C. Passier, Tom Kamperman et al. · 2023 · Nature Communications
69. Unified framework for patient-derived, tumor-organoid-based predictive testing of standard-of-care therapies in metastatic colorectal cancer
    Tao Tan, Dmitri Mouradov, Margaret Lee, Grace Gard, Yumiko Hirokawa, Shan Li, Cong Lin, Fuqiang Li, Huijuan Luo, Kui Wu et al. · 2023 · Cell Reports Medicine
70. Early-Onset colorectal Cancer: From the laboratory to the clinic
    Annalice Gandini, Julien Taı̈eb, Hélène Blons, Jeanne Netter, Pierre Laurent‐Puig, Claire Gallois · 2024 · Cancer Treatment Reviews
71. Advancing cancer research through organoid technology
    Guolong Zeng, Yifan Yu, Meiting Wang, Jiaxing Liu, Guangpeng He, Shaolan Yu, Huining Yan, Liang Yang, Hangyu Li, Xueqiang Peng · 2024 · Journal of Translational Medicine
72. Phenotypic Analysis of Organoids by Proteomics
    Alexis Gonneaud, Claude Asselin, François Boudreau, François‐Michel Boisvert · 2017 · PROTEOMICS
73. Concise Review: Emerging Drugs Targeting Epithelial Cancer Stem-Like Cells
    Mehreen Ahmed, Kritika Chaudhari, Roya Babaei‐Jadidi, Lodewijk V. Dekker, Abdolrahman Shams Nateri · 2017 · Stem Cells
74. Next-generation sequencing implicates oncogenic roles for p53 and JAK/STAT signaling in microcystic adnexal carcinomas
    May P. Chan, Komal R. Plouffe, Chia‐Jen Liu, Nallasivam Palanisamy, Shannon L. Carskadon, Lili Zhao, Rosalynn M. Nazarian, Alison B. Durham, Timothy M. Johnson, Aleodor A. Andea et al. · 2019 · Modern Pathology
75. Growth rate alterations of human colorectal cancer cells by 157 gut bacteria
    Rahwa Taddese, Daniel Rios Garza, Lilian N. Ruiter, Marien Isaäk de Jonge, Clara Belzer, Steven Aalvink, Irıs D. Nagtegaal, Bas E. Dutilh, Annemarie Boleij · 2020 · Gut Microbes
76. Large-scale pharmacogenomic studies and drug response prediction for personalized cancer medicine
    Fangyoumin Feng, Bihan Shen, Xiaoqin Mou, Yixue Li, Hong Li · 2021 · Journal of genetics and genomics/Journal of Genetics and Genomics
77. Collective metastasis: coordinating the multicellular voyage
    Emma D. Wrenn, Yin Cheng Huang, Kevin Cheung · 2021 · Clinical & Experimental Metastasis
78. Humans in a Dish: The Potential of Organoids in Modeling Immunity and Infectious Diseases
    Nino Iakobachvili, Peter J. Peters · 2017 · Frontiers in Microbiology
79. Toward improved in vitro models of human cancer
    Ayuso, Jose M., Park, Keon-Young, Virumbrales-Muñoz, María, Beebe, David J. · 2021 · APL Bioengineering
80. Establishment of patient-derived tumor organoids to functionally inform treatment decisions in metastatic colorectal cancer
    Giulia Martini, Valentina Belli, Stefania Napolitano, Vincenza Ciaramella, Davide Ciardiello, A. Belli, F. Izzo, Antonio Avallone, Francesco Selvaggi, Francesco Menegon Tasselli et al. · 2023 · ESMO Open
81. The predictive link between matrix and metastasis
    Lauren E. Barney, LE Jansen, SR Polio, S Galarza, Maureen E. Lynch, Shelly R. Peyton · 2016 · Current Opinion in Chemical Engineering
82. The genetic heterogeneity of colorectal cancer predisposition - guidelines for gene discovery
    Marc‐Manuel Hahn, Richarda M. de Voer, Nicoline Hoogerbrugge, Marjolijn J. L. Ligtenberg, Roland P. Kuiper, Ad Geurts van Kessel · 2016 · Cellular Oncology
83. High-Throughput Screening of Combinatorial Immunotherapies with Patient-Specific In Silico Models of Metastatic Colorectal Cancer
    Jakob Nikolas Kather, Pornpimol Charoentong, Meggy Suarez‐Carmona, Esther Herpel, Fee Klupp, Alexis B. Ulrich, Martin Schneider, Inka Zoernig, Tom Luedde, Dirk Jaeger et al. · 2018 · Cancer Research
84. Sphere‑forming assay vs. organoid culture: Determining long‑term stemness and the chemoresistant capacity of primary colorectal cancer cells
    Hui Zhao, Yan Chang, Yibing Hu, Lei Mu, Kaiyu Huang, Qiling Li, Xiaolan Li, Deding Tao, Jichao Qin · 2019 · International Journal of Oncology
85. Modeling rectal cancer to advance neoadjuvant precision therapy
    Harinarayanan Janakiraman, Yun Zhu, Scott A. Becker, Cindy Wang, Ashley W. Cross, Emily Curl, David Lewin, Brenda J. Hoffman, Graham Walter Warren, Elizabeth Goodwin Hill et al. · 2020 · International Journal of Cancer
86. Patient-Derived Tumor Organoids for Drug Repositioning in Cancer Care: A Promising Approach in the Era of Tailored Treatment
    Silvia Vivarelli, Saverio Candido, Giuseppe Caruso, Luca Falzone, Massimo Libra · 2020 · Cancers
87. Comparative Analysis of Patient-Matched PDOs Revealed a Reduction in OLFM4-Associated Clusters in Metastatic Lesions in Colorectal Cancer
    Takuya Okamoto, David A. duVerle, Katsuyuki Yaginuma, Yasuko Natsume, Hitomi Yamanaka, Daisuke Kusama, Mayuko Fukuda, Mayuko Yamamoto, Fanny Perraudeau, Upasna Srivastava et al. · 2021 · Stem Cell Reports
88. Patient-Derived Cancer Organoids for Precision Oncology Treatment
    Mark N. Pernik, Cylaina E. Bird, Jeffrey Isaac Traylor, Diana D. Shi, Timothy E. Richardson, Samuel K. McBrayer, Kalil G. Abdullah · 2021 · Journal of Personalized Medicine
89. Characterization of RNF43 frameshift mutations that drive Wnt ligand‐ and R ‐spondin‐dependent colon cancer
    Daisuke Yamamoto, Hiroko Oshima, Dong Wang, Haruna Takeda, Kenji Kita, Xuelian Lei, Mizuho Nakayama, Kazuhiro Murakami, Takashi Ohama, Hirofumi Takemura et al. · 2022 · The Journal of Pathology
90. Culture-Associated DNA Methylation Changes Impact on Cellular Function of Human Intestinal Organoids
    Edgar, Rachel D., Perrone, Francesca, Foster, April R., Payne, Felicity, Lewis, Sophia, Nayak, Komal M., Kraiczy, Judith, Cenier, Aurélie, Torrente, Franco, Salvestrini, Camilla et al. · 2022 · Cellular and Molecular Gastroenterology and Hepatology
91. An improved method for culturing patient-derived colorectal cancer spheroids
    Hiroyuki Miyoshi, Hisatsugu Maekawa, Fumihiko Kakizaki, Tadayoshi Yamaura, Kenji Kawada, Yoshiharu Sakai, Makoto Mark Taketo · 2018 · Oncotarget
92. Genome engineering of stem cell organoids for disease modeling
    Sun, Yingmin, Ding, Qiurong · 2017 · Protein & Cell
93. Modeling APC mutagenesis and familial adenomatous polyposis using human iPS cells
    Sommer, Cesar A., Capilla, Amalia, Molina-Estevez, Francisco J., Gianotti-Sommer, Andreia, Skvir, Nicholas, Caballero, Ignacio, Chowdhury, Sanjib, Mostoslavsky, Gustavo · 2018 · PLOS ONE
94. A Precision Medicine Drug Discovery Pipeline Identifies Combined CDK2 and 9 Inhibition as a Novel Therapeutic Strategy in Colorectal Cancer
    Jason A. Somarelli, Roham Salman Roghani, Ali Sanjari Moghaddam, Beatrice C. Thomas, Gabrielle Rupprecht, Kathryn E. Ware, Erdem Altunel, John B. Mantyh, So Young Kim, Shannon J. McCall et al. · 2020 · Molecular Cancer Therapeutics
95. Lung cancer organoids, a promising model still with long way to go
    Haochuan Ma, Yan-juan Zhu, Rui Zhou, Yaya Yu, Zhenzhen Xiao, Hai-bo Zhang · 2022 · Critical Reviews in Oncology/Hematology
96. The Role of Fusobacterium nucleatum in Colorectal Cancer Cell Proliferation and Migration
    Zihong Wu, Qiong Ma, Ying Guo, Fengming You · 2022 · Cancers
97. Organoids: opportunities and challenges of cancer therapy
    Xianjie Jiang, Linda Oyang, Peng Qiu, Qiang Liu, Xuemeng Xu, Nayiyuan Wu, Shiming Tan, Wenjuan Yang, Yaqian Han, Jinguan Lin et al. · 2023 · Frontiers in Cell and Developmental Biology
98. Biomaterial-assisted organoid technology for disease modeling and drug screening
    Yunyuan Shao, Juncheng Wang, Anqi Jin, Shicui Jiang, Lanjie Lei, Liangle Liu · 2024 · Materials Today Bio
99. Looking beyond the cancer cell for effective drug combinations
    Jonathan R. Dry, Mi Yang, Julio Sáez-Rodríguez · 2016 · Genome Medicine
100. Induction of differentiation of intrahepatic cholangiocarcinoma cells to functional hepatocytes using an organoid culture system
     Yoshimasa Saito, Toshiaki Nakaoka, Toshihide Muramatsu, Hidenori Ojima, Aoi Sukeda, Yuko Sugiyama, Ryoei Uchida, Ryo Furukawa, Aya Kitahara, Toshiro Sato et al. · 2018 · Scientific Reports